Jeremy Crisp, Executive Vice President and Chief Innovation Officer, Connecticut Innovations
Connecticut is serious about growing bioscience. So serious, in fact, that the state legislature this year established the $200 million, 10-year, evergreen Connecticut Bioscience Innovation Fund (CBIF) to help accelerate bioscience activities in Connecticut.
Jeremy Crisp, Ph.D., who previously headed global alliance management for Novartis Institutes for BioMedical Research, was appointed to lead the fund. He joined Connecticut Innovations (CI), which was designated to manage the fund, in late August and serves as CI’s executive vice president and chief innovation officer.